IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SACCHETTI, Emilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.349
AS - Asia 5.049
EU - Europa 4.948
SA - Sud America 851
AF - Africa 99
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 13
Totale 22.339
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.189
CN - Cina 2.060
SG - Singapore 1.500
UA - Ucraina 1.219
IT - Italia 1.209
BR - Brasile 731
HK - Hong Kong 645
DE - Germania 627
PL - Polonia 399
GB - Regno Unito 362
FI - Finlandia 288
RU - Federazione Russa 237
VN - Vietnam 214
IE - Irlanda 196
IN - India 195
TR - Turchia 191
FR - Francia 138
CA - Canada 91
SE - Svezia 66
AR - Argentina 51
BD - Bangladesh 49
MX - Messico 44
ZA - Sudafrica 44
CZ - Repubblica Ceca 43
BE - Belgio 42
NL - Olanda 39
ID - Indonesia 31
JP - Giappone 25
SA - Arabia Saudita 25
AU - Australia 22
EC - Ecuador 22
ES - Italia 21
IR - Iran 19
PK - Pakistan 17
IQ - Iraq 16
MA - Marocco 15
EU - Europa 12
UZ - Uzbekistan 12
VE - Venezuela 12
LT - Lituania 11
AT - Austria 10
CH - Svizzera 10
MU - Mauritius 10
CO - Colombia 9
EG - Egitto 9
KE - Kenya 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
GR - Grecia 7
JM - Giamaica 7
NZ - Nuova Zelanda 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
CL - Cile 6
PT - Portogallo 6
JO - Giordania 5
PH - Filippine 5
AL - Albania 4
IL - Israele 4
NP - Nepal 4
AM - Armenia 3
BG - Bulgaria 3
LA - Repubblica Popolare Democratica del Laos 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
SI - Slovenia 3
TN - Tunisia 3
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DZ - Algeria 2
ET - Etiopia 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
OM - Oman 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
SD - Sudan 1
SN - Senegal 1
Totale 22.338
Salva come PNG Salva come JPEG
Città #
Fairfield 1.347
Woodbridge 1.195
Jacksonville 894
Ashburn 864
Houston 815
Singapore 735
Hong Kong 642
Ann Arbor 606
Chandler 588
Seattle 535
Cambridge 514
Wilmington 483
Beijing 411
Warsaw 396
Princeton 358
Nanjing 320
New York 313
Dublin 192
Brescia 159
Istanbul 155
Helsinki 144
Los Angeles 144
The Dalles 135
Milan 122
Nanchang 120
Lancaster 101
Shenyang 101
Des Moines 95
Dearborn 94
Changsha 90
Hebei 89
Jinan 85
Moscow 78
Munich 77
Tianjin 77
Buffalo 75
Ho Chi Minh City 73
Dallas 60
Shanghai 59
Redondo Beach 56
São Paulo 56
San Francisco 55
Jiaxing 53
San Diego 50
Chicago 49
Boardman 46
Ningbo 38
Hangzhou 36
Hanoi 36
Zhengzhou 35
Washington 34
London 33
San Mateo 33
Inzago 32
Lanzhou 31
Rio de Janeiro 30
Guangzhou 29
Rome 29
Santa Clara 29
Toronto 28
Brussels 27
Norwalk 27
Taizhou 27
Turku 27
Montreal 26
Brno 25
Kunming 25
Leawood 24
Romola 24
Tokyo 24
Brooklyn 23
Verona 22
Haikou 21
Denver 19
Augusta 18
Johannesburg 18
Mantova 18
Belo Horizonte 17
Brugherio 17
Frankfurt am Main 17
Stockholm 17
Taiyuan 17
Atlanta 16
Mexico City 15
Olomouc 15
Riyadh 15
Bareggio 14
Berchem 14
Candia 14
Dong Ket 14
Olgiate Olona 14
Orange 14
Seregno 14
Boston 13
Fuzhou 13
Hefei 13
Charlotte 12
Coventry 12
Curitiba 12
Jakarta 12
Totale 14.885
Salva come PNG Salva come JPEG
Nome #
Analysis of DTI brain data and implementation in a novel software (DTILAB) 894
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 310
New Copy Number Variations in Schizophrenia 302
Compound heterozygosity for a large CNV deletion and a rare missense mutation in the FSTL5 gene of a patient affected by schizophrenia. 269
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 230
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 225
Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia 212
Is structured group psychoeducation for bipolar patients effective in ordinary mental health services? A controlled trial in Italy 208
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: The QUERISOLA trial. 185
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 180
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 177
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 176
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 173
Gene per la neuregulina 1 e schizofrenia: ulteriori evidenze di associazione 169
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 169
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 168
Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia? 168
Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. 166
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 166
Cognitive remediation in schizophrenia. 164
A STUDY OF EFFECTIVENESS OF STRUCTURED GROUP PSYCHOEDUCATION FOR BIPOLAR PATIENTS. A CONTROLLED TRIAL IN ITALY 163
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 162
Comparison of quetiapine (‘Seroquel’), olanzapine and risperidone in a randomized study in patients with schizophrenia. 159
Comparison of quetiapine, olanzapine and risperidone in schizophrenia. 156
Schizotassia 154
Comparison of Quetiapine, Olanzapine, and Risperidone in Patients With Schizophrenia: Interim Results of a Randomised, Rater-blinded Study. 154
Analysis of Copy Number Variations in Schizophrenia Italian Patients 151
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 151
A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment. 150
Depressive disorders and personality variables in HIV positive and negative intravenous drug-users 150
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 149
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 149
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 148
Adherence to antipsychotics in schizophrenia. 148
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study 147
Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia. 146
Are SSRI antidepressants a clinically homogeneous class of compounds? 145
Cognitive remediation in schizophrenia: a controlled study 145
Virological and immunological study of schizophrenic patients in relation to CT scan abnormality. 145
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 144
The role of the cytochine network in schizophrenia: an overview. 144
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 142
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia 142
Interim results of a randomised, rater-blinded study comparing quetiapine, olanzapine and risperidone in patients with schizophrenia. 142
Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis 138
Patterns of Brain Structural Changes in First-Contact, Antipsychotic Drug-Naive Patients with Schizophrenia. 137
Deranged anterior pituitary responsiveness to hypothalamic hormones in depressed patients 136
Season of birth and cerebral ventricular enlargement in schizophrenia 136
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 135
Self-ordered pointing and visual conditional associative learning tasks in drug-free schizophrenia spectrum disorder patients. 135
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 135
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 134
Non pharmacological strategies to enhance adherence and continuity of care in schizophrenia. 134
Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy. 133
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 133
Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial. 132
Cortical atrophy in schizophrenia: prevalence and associated features 131
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 131
A multimodal imaging study of never-medicated adults with schizophrenia 130
CT scan abnormalities and outcome of chronic schizophrenia 128
Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. 128
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 128
Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders 128
Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia. 127
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 127
Early life events and affective disorder revisited. 126
Cytokine profiles in drug-naive schizophrenic patients. 125
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. 125
Risk of stroke with typical and atypical anti-psychotics: a retrospective cohort study including unexposed subjects. 124
La cognitività sociale nella schizofrenia: modelli interpretativi e strategie di intervento 124
Fertility and marital status in mood disorders: relationship with age at onset. 124
Post-traumatic stress disorder and subthreshold post-traumatic stress disorder in recent male asylum seekers: An expected but overlooked “European” epidemic 123
Immediate and 8-Month Impact of a Medical Educational Course for General Practitioners on Knowledge About Schizophrenia and Its Treatment: Results of a 3-Phase Study From Brescia, Italy. 122
Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report. 122
Structural brain abnormalities in bipolar disorder: what meta-analyses tell us 122
Additional Evidence for White Matter Damage in Never-Medicated Adults with Schizophrenia and Schizophreniform Disorder 121
Carlo Lorenzo Cazzullo (1915-2010): father of Italian psychiatry 121
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 120
Variables Associated With General Practitioners' Knowledge About and Diagnostic Skills for Schizophrenia 120
DIRECT TRANSITION TO LONG-ACTING RISPERIDONE--ANALYSIS OF LONG-TERM EFFICACY. 120
Incidence of diabetes in a general practice population: a database cohort study on the relationship with haloperidol, olanzapine, risperidone or quetiapine exposure. 119
H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients. 119
Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review 119
CLINICAL ASSESSMENT OF COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA THROUGH THE SCHIZOPHRENIA COGNITION RATING SCALE: A VALIDATION STUDY IN THE ITALIAN POPULATION 119
Neuromorphological correlates of mood disorders: focus on cerebral ventricular enlargement. 119
Exome sequencing of schizophrenia patients with high level of homozygosity identifies a homozygous novel mutation that reduces the glutamate acid decarboxylase 67 (GAD67) activity 119
Brain morphology in schizophrenia: a 2-to-5 year CT scan follow-up study 118
Antipsychotics, antidepressants, anticonvulsants, and placebo on symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials 118
Variables associated with the hospitalization of psychiatric emergencies evaluated in the community. 117
Long-term remission in schizophrenia and related psychoses with long-acting risperidone: results obtained in an open-label study with an observation period of 18 months. 117
Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample 117
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 117
Timing of stroke in elderly people exposed to typical and atypical antipsychotics: a replication cohort study after the paper of Kleijer, et al. 117
EEG power spectrum profile and structural CNS characteristics in schizophrenia. 115
Reducing the "revolving door" phenomenon. 114
Change in core symptoms of borderline personality disorder by tDCS: A pilot study 114
New Copy Number Variations in Schizophrenia Italian Patients 113
Detection of high level of autozygosity in a group of Italian schizophrenia patients 113
Is ventricular enlargement a variable of interest for family studies in schizophrenia? 113
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients 113
Totale 15.242
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.513
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.905 0 0 0 0 0 311 140 314 373 295 368 104
2021/20221.439 113 267 26 66 32 65 69 90 82 166 132 331
2022/20231.589 218 24 17 163 129 430 1 179 281 17 56 74
2023/20241.464 95 35 115 109 73 376 61 51 277 28 19 225
2024/20252.880 38 39 42 340 361 238 216 95 257 240 613 401
2025/20263.330 663 765 388 829 548 137 0 0 0 0 0 0
Totale 22.802